Navinta Infringed Abraxis' Naropin Patents: Judge
Generic-drug manufacturer Navinta LLC has been found liable for infringing three patents for Abraxis BioScience Inc.'s injectable pain management drug Naropin....To view the full article, register now.
Already a subscriber? Click here to view full article